1
|
Iannaccone M, DE Filippo O, Montabone A, Marengo G, Maltese L, Ugo F, Quadri G, Mennuni M, Secco GG, Taglialatela V, Cinconze S, Moretti C, Truffa A, Gambino A, Boccuzzi G, Infantino V, Conrotto F, Lupi A, Varbella F, Patti G, Rognoni A, Musumeci G, Prati F, DE Ferrari GM, D'Ascenzo F. OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT. Minerva Cardiol Angiol 2023:S2724-5683.22.06144-0. [PMID: 36847434 DOI: 10.23736/s2724-5683.22.06144-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/01/2023]
Abstract
BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), percutaneous coronary intervention (PCI) of the culprit lesion significantly reduces the risk of cardiovascular death. However, the management of non-culprit lesions in patients with the multivessel disease remains a matter of debate in this setting. It's still unclear if a morphological OCT-guided approach, identifying coronary plaque instability, may provide a more specific treatment compared with a standard angiographic/functional approach. METHODS OCT-Contact is a prospective, multicenter, open-label, non-inferiority randomized controlled trial. Patients with STEMI with successful primary PCI of the culprit lesion will be enrolled after the index PCI. Patients will be deemed eligible if a critical coronary lesion other than the culprit (associated with a diameter of stenosis ≥50%) will be identified during the index angiography. Patients will be randomized in a 1:1 fashion to OCT-guided PCI of non-culprit lesions (Group A) vs. complete PCI (Group B). PCI in group A will be undertaken according to criteria of plaque vulnerability, while in group B the use of fractional flow reserve will be left at the operators' discretion. Major-adverse cardiovascular events (MACE) are a composite of all-cause mortality, non-fatal myocardial infarction (MI) (excluding peri-procedural MI), unplanned revascularization, and NYHA IV heart failure) will be the primary efficacy outcome. Single components of MACE along with cardiovascular mortality will be the secondary endpoints. . Safety endpoints will embrace worsening of renal failure, procedural complications, and bleedings. Patients will be followed for 24 months after randomization. RESULTS A sample size of 406 patients (203 per group) is required to provide the analysis an 80% power to detect a non-inferiority in the primary endpoint with an alpha error set at 0.05 and a non-inferiority limit of 4%. CONCLUSIONS A morphological OCT-guided approach may be a more specific treatment compared with the standard angiographic/functional approach in non-culprit lesions of STEMI patients.
Collapse
Affiliation(s)
- Mario Iannaccone
- Division of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy -
| | - Ovidio DE Filippo
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| | - Andrea Montabone
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| | - Giorgio Marengo
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| | - Ludovica Maltese
- Division of Cardiology, Sant'Andrea di Vercelli, Hospital, ASL VC, Vercelli, Italy
| | - Fabrizio Ugo
- Division of Cardiology, Sant'Andrea di Vercelli, Hospital, ASL VC, Vercelli, Italy
| | - Giorgio Quadri
- Division of Cardiology, Ospedale degli Infermi, ASL TO 3, Rivoli, Turin, Italy
| | - Maro Mennuni
- Division of Cardiology, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy
| | - Gioel G Secco
- Division, of Cardiology, Ss. Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy
| | | | | | - Claudio Moretti
- Division of Cardiology, Hospital, of Chivasso, ASL TO 4, Chivasso, Turin, Italy
| | | | - Alfonso Gambino
- Division of Cardiology, Hospital of Moncalieri, ASL TO 3 Moncalieri, Moncalieri, Turin, Italy
| | - Giacomo Boccuzzi
- Division of Cardiology, San Giovanni Bosco Hospital, ASL Città di Torino, Turin, Italy
| | - Vincenzo Infantino
- Division of Cardiology, Hospital of Ciriè, ASL TO 4, Ciriè, Turin, Italy
| | - Federico Conrotto
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| | - Alessandro Lupi
- Division of Cardiology, Hospital of Domodossola, Domodossola, Verbano-Cusio-Ossola, Italy
| | - Ferdinando Varbella
- Division of Cardiology, Ospedale degli Infermi, ASL TO 3, Rivoli, Turin, Italy
| | - Giuseppe Patti
- Division of Cardiology, Maggiore della Carità Hospital, University of Eastern Piedmont, Novara, Italy
| | - Andrea Rognoni
- Division, of Cardiology, Hospital of Biella, Biella, Italy
| | | | - Francesco Prati
- Centro, per la Lotta Contro L'Infarto-CLI Foundation, Rome, Italy.,UniCamillus - Saint Camillus International University, of Health Sciences, Rome, Italy
| | - Gaetano M DE Ferrari
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| | - Fabrizio D'Ascenzo
- Division of Cardiology, Città della Salute e Scienza, University of Turin, Turin, Italy
| |
Collapse
|
2
|
Cerrato E, Giacobbe F, Quadri G, Macaya F, Bianco M, Mori R, Biolè CA, Boi A, Bettari L, Rolfo C, Ferrari F, Annibali G, Scappaticci M, Pavani M, Barbero U, Buccheri D, Cavallino C, Lombardi P, Bernelli C, D'Ascenzo F, Infantino V, Gambino A, Cinconze S, Rognoni A, Montagna L, Porto I, Musumeci G, Escaned J, Varbella F. Corrigendum to: Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry. Eur Heart J 2021; 43:87. [PMID: 34654925 DOI: 10.1093/eurheartj/ehab720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
3
|
Benenati S, Giacobbe F, Zingarelli A, Alessandra TG, Lombardi P, Musumeci G, Cinconze S, Barbero U, Iannaccone M, Patti G, Rognoni A, Menunni M, Di Leo A, Infantino V, Gambino A, D’Ascenzo F, Bruno F, Pavani M, Gagnor A, Ugo F, Cavallino C, Campo GC, Bettari L, Cassano F, Perfetti M, Scappaticci M, Buccheri D, Bordoni E, Bernelli C, Boi A, Mori R, Macaya F, Escaned J, Cerrato E, Porto I. 580 Percutaneous coronary intervention or medical therapy as initial management strategy of patients with spontaneous coronary artery dissections: insight from the multicentre, international dissezioni spontanee coronariche (disco) registry. Eur Heart J Suppl 2021. [DOI: 10.1093/eurheartj/suab140.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
Abstract
Aims
Whether patients with spontaneous coronary artery dissection (SCAD) should undergo an initial conservative management or immediate revascularization through percutaneous coronary intervention (PCI) remains debated. To investigate the frequency and predictors of choosing a strategy of immediate PCI for SCAD, and to compare the clinical outcomes of immediate PCI patients with those undergoing an initial strategy of medical management.
Methods and results
369 patients enrolled in the multicentre international DIssezioni Spontanee COronariche (DISCO) registry between January 2009 and December 2020 were included. The primary endpoint was major adverse cardiovascular events (MACE), a composite of cardiac death, non-fatal myocardial infarction (MI) and any PCI. 240 (65%) patients underwent initial medical management, whereas 129 (35%) had immediate PCI. PCI patients presented more frequently with ST segment-elevation myocardial infarction (STEMI) (68.2% vs. 35%, P < 0.001) and had higher frequency of proximal coronary segment SCAD (31.8% vs. 6.7%, P < 0.001), Thrombolysis in Myocardial infarction (TIMI) flow grade 0–1 (54.3% vs. 20.4%, P < 0.001) and multivessel SCAD (18.6% vs. 9.2%, P = 0.015), as well as a more severe diameter stenosis [99% (100–90) vs. 90% (99–75), P < 0.001]. At multivariate logistic regression, STEMI at presentation (vs. NSTE-ACS, OR: 3.30 95% CI: 1.56–7.12, P = 0.002), proximal coronary segment involvement (OR: 5.43, 95% CI: 1.98–16.45, P = 0.002), TIMI flow grade 0–1 and 2 (respectively, vs. grade 3: OR: 3.22 95% CI: 1.08–9.96, P = 0.038; and OR: 3.98; 95% CI: 1.38–11.80, P = 0.009) and diameter stenosis (per 5% increase, OR: 1.13; 95% CI: 1.01–1.28, P = 0.037) were predictors of immediate PCI, whereas the angiographic subtype 2B predicted a conservative approach (OR: 0.25; 95% CI: 0.07–0.83, P = 0.026). The frequency of in-hospital major adverse cardiac events did not differ between medically and PCI-treated patients. At 2-year follow-up, there were no differences with respect to the composite of MACE (11.7% vs. 13.9%, P = 0.47) and the individual components of cardiovascular death (0.4% vs. 0.7%, P = 0.65), non-fatal MI (8.3% vs. 9.3%, P = 0.92), and any PCI (8.7% vs. 12.4%, P = 0.23).
Conclusions
The choice between an immediate medical or PCI management of SCAD is mostly driven by clinical presentation and procedural aspects. In the DISCO cohort, the primary treatment approach was not associated with the risk of short-to-midterm adverse events.
Collapse
Affiliation(s)
- Stefano Benenati
- Dipartimento di Medicina Interna (DIMI), University of Genoa, Genoa, Italy
| | - Federico Giacobbe
- Cardiology Department, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
| | - Antonio Zingarelli
- Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino—IRCCS Italian Cardiovascular Network, Italy
| | | | - Primiano Lombardi
- Interventional Cardiology Unit, Cardinal Massaia Civil Hospital, Asti, Italy
| | | | | | - Umberto Barbero
- Interventional Cardiology Unit, Ospedale Maggiore SS. Annunziata, Savigliano, Cuneo, Italy
| | - Mario Iannaccone
- Interventional Cardiology Unit, Ospedale Maggiore SS. Annunziata, Savigliano, Cuneo, Italy
| | - Giuseppe Patti
- Cardiology Department, Ospedale Maggiore Della Carità, Novara, Italy
| | - Antonio Rognoni
- Cardiology Department, Ospedale Maggiore Della Carità, Novara, Italy
| | - Marco Menunni
- Cardiology Department, Ospedale Maggiore Della Carità, Novara, Italy
| | - Angelo Di Leo
- Division of Cardiology, Ospedale Civile di Ciriè, Turin, Italy
| | | | - Alfonso Gambino
- Interventional Cardiology Unit, Santa Croce Hospital, Moncalieri, Turin, Italy
| | - Fabrizio D’Ascenzo
- Cardiology Department, A.O.U. Città della Salute e della Scienza di Torino, Turin, Italy
| | - Francesco Bruno
- Interventional Cardiology Unit, Santa Croce Hospital, Moncalieri, Turin, Italy
| | - Marco Pavani
- Cardiology Department, A.O. Ordine Mauriziano, Ospedale Umberto I, Turin, Italy
| | | | | | | | | | - Luca Bettari
- Interventional Cardiology Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
| | - Francesco Cassano
- SS. Annunziata Hospital, Taranto, Italy
- Ospedale di Venere, Bari, Italy
| | | | | | - Dario Buccheri
- Interventional Cardiology Unit, S. Antonio Abate Hospital, Trapani, Italy
| | | | - Chiara Bernelli
- Interventional Cardiology Unit, Santa Corona Hospital, Pietra Ligure, Savona, Italy
| | | | - Ricardo Mori
- Hospital Clinico San Carlos IdISSC, Complutense University of Madrid, Madrid, Spain
| | - Fernando Macaya
- Hospital Clinico San Carlos IdISSC, Complutense University of Madrid, Madrid, Spain
| | - Javier Escaned
- Hospital Clinico San Carlos IdISSC, Complutense University of Madrid, Madrid, Spain
| | - Enrico Cerrato
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy
- Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | - Italo Porto
- Dipartimento di Medicina Interna (DIMI), University of Genoa, Genoa, Italy
- Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino—IRCCS Italian Cardiovascular Network, Italy
| |
Collapse
|
4
|
Laurita T, Pappalardo I, Chiummiento L, D'Orsi R, Funicello M, Santarsiero A, Marsico M, Infantino V, Todisco S, Lupattelli P. Synthesis of new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans and evaluation of their anti-inflammatory activity. Bioorg Med Chem Lett 2021; 49:128264. [PMID: 34280408 DOI: 10.1016/j.bmcl.2021.128264] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2021] [Revised: 07/06/2021] [Accepted: 07/11/2021] [Indexed: 01/03/2023]
Abstract
In the present study we synthesized new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans, starting from suitable trans 2,3-diaryloxiranes, using regio- and stereoselective nucleophilic oxiranyl ring-opening reactions. The compounds were tested as anti-inflammatories in U937 cells. All compounds showed a significant role in inhibiting the NF-κB pathway and were able to restore normal ROS and NO level upon LPS activation. Moreover, regarding inhibition of ACLY, enantioenriched (50% ee) 7a50 showed more potency than the racemic counterpart 7arac, together with a higher reduction of prostaglandin E2 production, thus suggesting a stereoselective interaction in this pathway.
Collapse
Affiliation(s)
- T Laurita
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - I Pappalardo
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - L Chiummiento
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - R D'Orsi
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - M Funicello
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - A Santarsiero
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - M Marsico
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - V Infantino
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - S Todisco
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy
| | - P Lupattelli
- Department of Sciences, University of Basilicata, via dell'ateneo lucano 10, 85100 Potenza, Italy.
| |
Collapse
|
5
|
Cerrato E, Giacobbe F, Quadri G, Macaya F, Bianco M, Mori R, Biolè CA, Boi A, Bettari L, Rolfo C, Ferrari F, Annibali G, Scappaticci M, Pavani M, Barbero U, Buccheri D, Cavallino C, Lombardi P, Bernelli C, D'Ascenzo F, Infantino V, Gambino A, Cinconze S, Rognoni A, Montagna L, Porto I, Musumeci G, Escaned J, Varbella F. Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry. Eur Heart J 2021; 42:3161-3171. [PMID: 34338759 DOI: 10.1093/eurheartj/ehab372] [Citation(s) in RCA: 71] [Impact Index Per Article: 23.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Revised: 02/23/2021] [Accepted: 06/07/2021] [Indexed: 12/16/2022] Open
Abstract
AIMS The role of antiplatelet therapy in patients with spontaneous coronary artery dissection (SCAD) undergoing initial conservative management is still a matter of debate, with theoretical arguments in favour and against its use. The aims of this article are to assess the use of antiplatelet drugs in medically treated SCAD patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes. METHODS AND RESULTS We investigated the 1-year outcome of patients with SCAD managed with initial conservative treatment included in the DIssezioni Spontanee COronariche (DISCO) multicentre international registry. Patients were divided into two groups according to SAPT or DAPT prescription. Primary endpoint was 12-month incidence of major adverse cardiovascular events (MACE) defined as the composite of all-cause death, non-fatal myocardial infarction (MI), and any unplanned percutaneous coronary intervention (PCI). Out of 314 patients included in the DISCO registry, we investigated 199 patients in whom SCAD was managed conservatively. Most patients were female (89%), presented with acute coronary syndrome (92%) and mean age was 52.3 ± 9.3 years. Sixty-seven (33.7%) were given SAPT whereas 132 (66.3%) with DAPT. Aspirin plus either clopidogrel or ticagrelor were prescribed in 62.9% and 36.4% of DAPT patients, respectively. Overall, a 14.6% MACE rate was observed at 12 months of follow-up. Patients treated with DAPT had a significantly higher MACE rate than those with SAPT [18.9% vs. 6.0% hazard ratios (HR) 2.62; 95% confidence intervals (CI) 1.22-5.61; P = 0.013], driven by an early excess of non-fatal MI or unplanned PCI. At multiple regression analysis, type 2a SCAD (OR: 3.69; 95% CI 1.41-9.61; P = 0.007) and DAPT regimen (OR: 4.54; 95% CI 1.31-14.28; P = 0.016) resulted independently associated with a higher risk of 12-month MACE. CONCLUSIONS In this European registry, most patients with SCAD undergoing initial conservative management received DAPT. Yet, at 1-year follow-up, DAPT, as compared with SAPT, was independently associated with a higher rate of adverse cardiovascular events (ClinicalTrial.gov id: NCT04415762).
Collapse
Affiliation(s)
- Enrico Cerrato
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.,Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | - Federico Giacobbe
- Cardiology Department, AOU Città della Salute e della Scienza di Torino, Turin, Italy
| | - Giorgio Quadri
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.,Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | - Fernando Macaya
- Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain
| | - Matteo Bianco
- Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Turin, Italy
| | - Ricardo Mori
- Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain
| | - Carlo Alberto Biolè
- Interventional cardiology unit, Cardinal Massaia Civil Hospital, Asti, Italy
| | | | - Luca Bettari
- Interventional cardiology unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy
| | - Cristina Rolfo
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.,Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | - Fabio Ferrari
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.,Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | - Gianmarco Annibali
- Cardiology Department, A.O. Ordine Mauriziano, Ospedale Umberto I, Turin, Italy
| | | | - Marco Pavani
- Interventional cardiology unit, Ospedale Maggiore Ss. Annunziata, Savigliano, CN, Italy
| | - Umberto Barbero
- Interventional cardiology unit, Ospedale Maggiore Ss. Annunziata, Savigliano, CN, Italy
| | - Dario Buccheri
- Interventional Cardiology Unit, S. Antonio Abate Hospital, Trapani, Italy
| | | | - Primiano Lombardi
- Interventional cardiology unit, Cardinal Massaia Civil Hospital, Asti, Italy
| | - Chiara Bernelli
- Interventional cardiology unit, Santa Corona Hospital, Pietra Ligure (SV), Italy
| | - Fabrizio D'Ascenzo
- Cardiology Department, AOU Città della Salute e della Scienza di Torino, Turin, Italy
| | | | - Alfonso Gambino
- Interventional cardiology unit, Santa Croce Hospital, Moncalieri, TO, Italy
| | - Sebastian Cinconze
- Cardiology Department, Azienda Ospedaliera S. Croce e Carle, Cuneo, Italy
| | - Andrea Rognoni
- Cardiology Department, Ospedale Maggiore della Carità, Novara, Italy
| | - Laura Montagna
- Division of Cardiology, A.O.U San Luigi Gonzaga, Orbassano, Turin, Italy
| | - Italo Porto
- Cardiovascular Disease Unit, IRCCS Ospedale Policlinico San Martino-IRCCS Italian Cardiovascular Network & Department of Internal Medicine, University of Genova, Genova, Italy
| | - Giuseppe Musumeci
- Cardiology Department, A.O. Ordine Mauriziano, Ospedale Umberto I, Turin, Italy
| | - Javier Escaned
- Hospital Clinico San Carlos IDISSC, Complutense University of Madrid, Madrid, Spain
| | - Ferdinando Varbella
- Interventional Cardiology Unit, San Luigi Gonzaga University Hospital, Orbassano, Turin, Italy.,Interventional Cardiology Unit, Rivoli Infermi Hospital, Rivoli, Turin, Italy
| | | |
Collapse
|
6
|
Gallone G, D'Ascenzo F, Ielasi A, Landra F, Stefanini GG, Di Biasi M, Mancone M, Tomai F, Infantino V, Rognoni A, Briguori C, Boccuzzi G, Smolka G, Chiarito M, Capodanno D, Chieffo A, Fabbiocchi F, Poli A, Tespili M, D'Urbano M, Giordano A, Escaned J, De Ferrari GM, Sardella G. Polymer-free biolimus-eluting stents or polymer-based zotarolimus-eluting stents for coronary bifurcation lesions. Cardiovasc Revasc Med 2021; 35:66-73. [PMID: 33903036 DOI: 10.1016/j.carrev.2021.04.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2021] [Revised: 03/22/2021] [Accepted: 04/02/2021] [Indexed: 11/30/2022]
Abstract
BACKGROUND A polymer-free biolimus-eluting stent (PF-BES) and a zotarolimus-eluting stent (ZES) recently showed similar clinical profiles and appear to be competing options in specific clinical settings of patients undergoing percutaneous coronary intervention (PCI). Whether they perform similarly also in complex procedural settings as coronary bifurcation lesions remains unaddressed. METHODS All consecutive patients undergoing coronary bifurcation PCI with PF-BES or the new iteration of the ZES from three large multicenter real-world registries were included. The primary outcome was major adverse cardiovascular events (MACE), a composite of all-cause death, myocardial infarction (MI), target lesion revascularization (TLR) and stent thrombosis (ST). Multiple analyses to adjust for baseline differences were carried out including propensity-score matching, propensity-score stratification and inverse-probability-weighting. Outcomes are reported according to Cox proportional hazard models censored at 400-day follow-up. RESULTS 1169 patients treated with PF-BES (n = 440) or ZES (n = 729) on the main branch of a coronary bifurcation lesion were included (mean age 69 ± 11 years, 75.4% male, 53.8% acute coronary syndrome at presentation, 26.6% left main bifurcation, median dual antiplatelet therapy duration 12 [range 12-12] months). MACE, all-cause death, TLR and ST tended towards non-statistically higher rates with the PF-BES as compared to the ZES. Higher MI and target vessel revascularization occurrence was observed with PF-BES. CONCLUSIONS In this large contemporary cohort of patients undergoing coronary bifurcation PCI, the occurrence of MACE was non-statistically different with the use of PF-BES and ZES devices. However, differences favoring the ZES device that may entail clinical relevance were observed. Further studies are needed to confirm these findings and explore whether they remain valid when a short dual antiplatelet therapy is adopted.
Collapse
Affiliation(s)
- Guglielmo Gallone
- Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy.
| | - Fabrizio D'Ascenzo
- Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy
| | - Alfonso Ielasi
- Interventional Cardiology Unit, Istituto Clinico S. Ambrogio, Milan, Italy
| | - Federico Landra
- Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy
| | | | - Maurizio Di Biasi
- Interventional Cardiology Unit, Ospedale Sacco, ASST Fatebenefratelli/Sacco, Milano, Italy
| | - Massimo Mancone
- Department of Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| | - Fabrizio Tomai
- Department of Cardiovascular Sciences, European Hospital, Rome, Italy
| | | | - Andrea Rognoni
- Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy
| | | | | | - Grzegorz Smolka
- Division of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland
| | - Mauro Chiarito
- Humanitas Clinical and Research Center IRCCS, Rozzano-Milan, Italy
| | - Davide Capodanno
- Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
| | - Alaide Chieffo
- Unit of Cardiovascular Interventions, IRCCS San Raffaele Hospital, Milan, Italy
| | - Franco Fabbiocchi
- Interventional Cardiology Unit, Centro Cardiologico Monzino, IRCCS, Department of Cardiovascular Sciences, Milan, Italy
| | - Arnaldo Poli
- Division of Cardiology, Ospedale di Legnano, ASST Milanese Ovest, Italy
| | - Maurizio Tespili
- Interventional Cardiology Unit, Istituto Clinico S. Ambrogio, Milan, Italy
| | - Maurizio D'Urbano
- Division of Cardiology, Ospedale di Magenta, ASST Milanese Ovest, Italy
| | | | - Javier Escaned
- Hospital Clínico San Carlos, IDISSC, and Universidad Complutense de Madrid, Madrid, Spain
| | - Gaetano M De Ferrari
- Division of Cardiology, Cardiovascular and Thoracic Department, Città della Salute e della Scienza, Turin, Italy
| | - Gennaro Sardella
- Department of Cardiovascular Sciences, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
| |
Collapse
|
7
|
Rondanelli M, Peroni G, Gasparri C, Infantino V, Naso M, Riva A, Petrangolini G, Perna S, Tartara A, Faliva MA. An overview on the correlation between blood zinc, zinc intake, zinc supplementation and bone mineral density in humans. Acta Ortop Mex 2021; 35:142-152. [PMID: 34731914] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/13/2023]
Abstract
INTRODUCTION In case of zinc (Zn) deficiency, this mineral becomes a nutrient limiting muscle and bone synthesis. The study in humans on zinc and bone health are few and no reviews have been published on this topic. So, the aim of this narrative review was to consider the state of the art on the correlation between blood zinc, daily zinc intake, zinc supplementation and bone mineral density. MATERIAL AND METHODS A narrative review was performed. RESULTS This review included 16 eligible studies: eight studies concern Zn blood; three studies concern Zn intake and five studies concern Zn supplementation. CONCLUSION Blood zinc levels seem to be lower in subjects with pathology related to bone metabolism. Regarding daily zinc intake, a high proportion of the population, more than 20%, seems to be at risk of having inadequate zinc intake. The literature suggests that an insufficient zinc intake (less than 3 mg/day) could be a risk factor for fractures and for development of osteopenia and osteoporosis. Zinc supplementation (40-50 g/day) could have beneficial effects on bone health in terms of maintaining bone mineral density and faster healing in the event of fractures, with even better results in situations of reduced intake zinc through food.
Collapse
Affiliation(s)
- M Rondanelli
- IRCCS Mondino Foundation
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia. Italy
| | - G Peroni
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia. Italy
| | - C Gasparri
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia. Italy
| | - V Infantino
- Department of Public Health, Experimental and Forensic Medicine, University of Pavia. Italy
| | - M Naso
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia. Italy
| | - A Riva
- Research and Development Department, Indena SpA
| | | | - S Perna
- Department of Biology, University of Bahrain, College of Science, Sakhir Campus
| | - A Tartara
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia. Italy
| | - M A Faliva
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia. Italy
| |
Collapse
|
8
|
Rondanelli M, Guido D, Faliva MA, Gasparri C, Peroni G, Iannello G, Nichetti M, Naso M, Infantino V, Spadaccini D, Perna S, Aquilani R. Effects of essential amino acid supplementation on pain in the elderly with hip fractures: a pilot, double-blind, placebo-controlled, randomised clinical trial. J BIOL REG HOMEOS AG 2020; 34:721-731. [PMID: 32462856 DOI: 10.23812/19-452-l-46] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- M Rondanelli
- IRCCS Mondino Foundation, Pavia, Italy.,Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy
| | - D Guido
- Epidemiology Unit, Agency for Health Protection of Milan, Milan, Italy
| | - M A Faliva
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - C Gasparri
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - G Peroni
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - G Iannello
- General Management, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', Pavia, Italy
| | - M Nichetti
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - M Naso
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - V Infantino
- University of Bari, Department of Biomedical Science and Human Oncology, Bari, Italy
| | - D Spadaccini
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona ''Istituto Santa Margherita'', University of Pavia, Pavia, Italy
| | - S Perna
- University of Bahrain, Department of Biology, College of Science, Sakhir Campus, Kingdom of Bahrain
| | - R Aquilani
- Department of Biology and Biotechnology University of Pavia
| |
Collapse
|
9
|
Barbero U, Moncalvo C, Trabattoni D, Pavani M, Amoroso GR, Bocchino PP, Truffa Giachet A, Saglietto A, Monticone S, Secco GG, Campo G, Verardi R, Iannaccone M, Galvani M, Ugo F, Infantino V, Olivotti L, Mennuni M, Vercellino M, Gili S, Zucchetti O, Casella G, Giammaria M, De Benedictis M, Tolomeo P, Doronzo B, Grosso Marra W, Rognoni A, Montefusco A, Patti G, Mancone M, De Ferrari GM, D’Ascenzo F. Gender differences in acute coronary syndromes patterns during the COVID-19 outbreak. Am J Cardiovasc Dis 2020; 10:506-513. [PMID: 33224602 PMCID: PMC7675165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Accepted: 09/29/2020] [Indexed: 06/11/2023]
Abstract
BACKGROUND Mortality from acute coronary syndromes (ACS) is strictly related to early management. As female patients usually experience longer delays before diagnosis and treatment, we assessed whether women were more affected by the dramatic drop in hospital admissions for ACS during the Covid-19 pandemic. METHODS We performed a retrospective analysis of clinical and angiographic characteristics of consecutive patients who were admitted for ACS at 15 hospitals in Northern Italy comparing men and women data. The study period was defined as the time between the first confirmed case of Covid-19 in Italy (February 20, 2020) and March 31, 2020. We compared hospitalization rates between the study period and two control periods: the corresponding period during the previous year (February 20 to March 31, 2019) and the earlier period during the same year (January 1 to February 19, 2020). Incidence rate ratios comparing the study period with each of the control periods were calculated with the use of Poisson regression. RESULTS Of the 547 patients who were hospitalized for ACS during the study period, only 127 (23%) were females, accounting for a mean of 3.1 admissions per day, while ACS hospitalized males were 420, with a mean of 10.2 admissions per day. There was a significant decrease driven by a similar reduction in ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation myocardial infarction (NSTEMI) diagnosis in both sexes compared to the control periods. A trend toward a greater reduction in admitted females was shown in the intra-year control period (46% admission reduction in females vs 37% in males, with females accounting for 26% of ACS, P=0.10) and a significant reduction when compared to the previous year control period (40% admission reduction in females vs 23% in males, with females accounting for 28% of ACS, P=0.03), mainly related to Unstable Angina diagnosis. CONCLUSION The Covid-19 pandemic period closed the gap between men and women in ACS, with similar rates of reduction of hospitalized STEMI and NSTEMI and a trend toward greater reduction in UA admission among women. Furthermore, many typical differences between males and females regarding ischemic heart disease presentations and vessel distribution were leveled.
Collapse
Affiliation(s)
| | | | - Daniela Trabattoni
- Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, University of MilanItaly
| | | | | | - Pier Paolo Bocchino
- Division of Cardiology, A.O.U Città della Salute e della Scienza di TorinoTurin, Italy
| | | | - Andrea Saglietto
- Division of Cardiology, A.O.U Città della Salute e della Scienza di TorinoTurin, Italy
| | - Silvia Monticone
- Division of Internal Medicine 4 and Hypertension Unit, Department of Medical Sciences, University of TurinTorino, Italy
| | - Gioel Gabrio Secco
- Department of Cardiology, Interventional Cardiology and Cardiac Surgery Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare ArrigoAlessandria, Italy
| | - Gianluca Campo
- Cardiology Unit, Azienda Ospedaliera Universitaria di FerraraFerrara, Italy
- Maria Cecilia Hospital, GVM Care & ResearchCotignola, Ravenna Italy
| | - Roberto Verardi
- Division of Cardiology, A.O.U Città della Salute e della Scienza di TorinoTurin, Italy
- Department of Cardiology, Maggiore Hospital Carlo Alberto PizzardiBologna, Italy
| | | | - Marcello Galvani
- U.O.C. Cardiologia, Dipartimento Cardiovascolare AUSL Romagna, Ospedale Morgagni, Forlì, e Unità di Ricerca Cardiovascolare, Fondazione Cardiologica SaccoForlì, Italy
| | - Fabrizio Ugo
- Division of Cardiology, Presidio Ospedaliero Sant’Andrea di VercelliVercelli, Italy
| | | | - Luca Olivotti
- Division of Cardiology, Ospedale Santa CoronaPietra Ligure, Italy
| | - Marco Mennuni
- Coronary Care Unit and Catheterization laboratory, A.O.U. Maggiore della CaritàNovara, Italy
| | - Matteo Vercellino
- Department of Cardiology, Interventional Cardiology and Cardiac Surgery Unit, Azienda Ospedaliera SS Antonio e Biagio e Cesare ArrigoAlessandria, Italy
| | - Sebastiano Gili
- Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, University of MilanItaly
| | - Ottavio Zucchetti
- Cardiology Unit, Azienda Ospedaliera Universitaria di FerraraFerrara, Italy
| | - Gianni Casella
- Department of Cardiology, Maggiore Hospital Carlo Alberto PizzardiBologna, Italy
| | | | | | - Paolo Tolomeo
- Cardiology Unit, Azienda Ospedaliera Universitaria di FerraraFerrara, Italy
| | | | | | - Andrea Rognoni
- Coronary Care Unit and Catheterization laboratory, A.O.U. Maggiore della CaritàNovara, Italy
| | - Antonio Montefusco
- Division of Cardiology, A.O.U Città della Salute e della Scienza di TorinoTurin, Italy
| | - Giuseppe Patti
- Coronary Care Unit and Catheterization laboratory, A.O.U. Maggiore della CaritàNovara, Italy
| | - Massimo Mancone
- Department of Cardiovascular, Respiratory, Nephrology, Anesthesiology and Geriatric Sciences, Sapienza University of RomeRome, Italy
| | | | - Fabrizio D’Ascenzo
- Division of Cardiology, A.O.U Città della Salute e della Scienza di TorinoTurin, Italy
| |
Collapse
|
10
|
Gallone G, D'Ascenzo F, Boccuzzi G, Cortese B, Di Biasi M, Omedè P, Capodanno D, Cerrato E, Vicinelli P, Infantino V, Poli A, Ugo F, Conrotto F, Grigis G, Varbella F, Latini RA, D'Urbano M, Montabone A, Senatore G, Ferrara E, D'Amico M, De Ferrari GM, Ielasi A. Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent. Catheter Cardiovasc Interv 2020; 96:E248-E256. [PMID: 32012453 DOI: 10.1002/ccd.28757] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/06/2020] [Accepted: 01/19/2020] [Indexed: 11/10/2022]
Abstract
BACKGROUND A large trial established the favorable profile of a new polymer-free biolimus A9-eluting stent (PF-BES) with a 1-month dual antiplatelet therapy (DAPT) in high bleeding risk (HBR) patients. This is the first study comparing outcomes for a 1-month versus longer DAPT strategies following PF-BES-percutaneous coronary intervention (PCI). METHODS All patients undergoing PF-BES-PCI (January 2016 to July 2018) were included in the multicenter CHANCE registry. Patients were stratified according to DAPT strategy at discharge (planned 1-month vs. planned >1-month). Primary outcomes were the 390-day estimates of a patient-oriented and of a device-oriented composite endpoints (POCE: death, myocardial infarction [MI] or target vessel revascularization; DOCE: cardiac death, target vessel-MI or ischemia-driven target lesion revascularization). Landmark analyses from 1-month post-PCI were carried. RESULTS Following PF-BES-PCI, 328(40.3%) and 485(59.6%) patients were discharged with 1-month and longer DAPT (12 months [6-12]), respectively. Patients with a previous or index MI were less likely to be discharged on 1-month DAPT. Patients prescribed with 1-month DAPT were more likely to be at HBR than those with longer DAPT (90.2% vs. 69.9%, p = .001). No between-groups differences in the primary outcomes (planned 1-month vs. planned >1-month DAPT: POCE 11.9% vs. 13.2%, p = .747; DOCE: 4.8% vs. 8.1%, p = .500) were observed, also after adjusting for confoundings (POCE: adjusted-hazard ratio [adj-HR] 1.26, 95%CI 0.74-2.13; DOCE: adj-HR 1.00, 95%CI 0.49-1.99). Landmark analyses showed similar results. CONCLUSIONS In a large all-comers registry of PF-BES PCI, no interaction of planned DAPT strategy (1-month vs. >1-month) with outcomes was found. This observation warrants investigation in adequately powered randomized studies (ClinicalTrials.gov NCT03622203).
Collapse
Affiliation(s)
- Guglielmo Gallone
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | - Fabrizio D'Ascenzo
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | | | - Bernardo Cortese
- U.O.C. Cardiologia, Ospedale Fatebenefratelli, ASST Fatebenefratelli/Sacco, Milano, Italy
| | - Maurizio Di Biasi
- U.O.C. Cardiologia, Ospedale Sacco, ASST Fatebenefratelli/Sacco, Milano, Italy
| | - Pierluigi Omedè
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | - Davide Capodanno
- Division of Cardiology, Ferrarotto Hospital, University of Catania, Catania, Italy
| | - Enrico Cerrato
- Department of Cardiology, Infermi Hospital, Rivoli, Italy
| | - Paolo Vicinelli
- U.O.C. Cardiologia, Ospedale di Magenta, ASST Milanese Ovest, Milano, Italy
| | | | - Arnaldo Poli
- U.O.C. Cardiologia, Ospedale di Legnano, ASST Milanese Ovest, Milano, Italy
| | - Fabrizio Ugo
- Division of Cardiology, San Giovanni Bosco, Torino, Italy
| | - Federico Conrotto
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | - Giulietta Grigis
- U.O.C. Cardiologia, Ospedale di Seriate, ASST Bergamo Est, Milano, Italy
| | | | - Roberto A Latini
- U.O.C. Cardiologia, Ospedale Fatebenefratelli, ASST Fatebenefratelli/Sacco, Milano, Italy
| | - Maurizio D'Urbano
- U.O.C. Cardiologia, Ospedale di Magenta, ASST Milanese Ovest, Milano, Italy
| | | | | | - Erika Ferrara
- U.O.C. Cardiologia, Ospedale di Legnano, ASST Milanese Ovest, Milano, Italy
| | - Maurizio D'Amico
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | - Gaetano M De Ferrari
- Division of Cardiology, Department of Internal Medicine, Città della Salute e della Scienza, Torino, Italy
| | - Alfonso Ielasi
- U.O. Cardiologia Clinica ed Interventistica, Istituto Clinico S. Ambrogio, Milano, Italy
| |
Collapse
|
11
|
De Filippo O, D'Ascenzo F, Angelini F, Bocchino PP, Conrotto F, Saglietto A, Secco GG, Campo G, Gallone G, Verardi R, Gaido L, Iannaccone M, Galvani M, Ugo F, Barbero U, Infantino V, Olivotti L, Mennuni M, Gili S, Infusino F, Vercellino M, Zucchetti O, Casella G, Giammaria M, Boccuzzi G, Tolomeo P, Doronzo B, Senatore G, Grosso Marra W, Rognoni A, Trabattoni D, Franchin L, Borin A, Bruno F, Galluzzo A, Gambino A, Nicolino A, Truffa Giachet A, Sardella G, Fedele F, Monticone S, Montefusco A, Omedè P, Pennone M, Patti G, Mancone M, De Ferrari GM. Reduced Rate of Hospital Admissions for ACS during Covid-19 Outbreak in Northern Italy. N Engl J Med 2020; 383:88-89. [PMID: 32343497 PMCID: PMC7224608 DOI: 10.1056/nejmc2009166] [Citation(s) in RCA: 742] [Impact Index Per Article: 185.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Ovidio De Filippo
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Fabrizio D'Ascenzo
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Filippo Angelini
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Pier Paolo Bocchino
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Federico Conrotto
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Andrea Saglietto
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Gioel Gabrio Secco
- Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
| | - Gianluca Campo
- Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy
| | - Guglielmo Gallone
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Roberto Verardi
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | | | | | | | - Fabrizio Ugo
- Presidio Ospedaliero Sant'Andrea di Vercelli, Vercelli, Italy
| | | | | | | | - Marco Mennuni
- Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy
| | | | | | - Matteo Vercellino
- Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
| | | | - Gianni Casella
- Ospedale Maggiore Carlo Alberto Pizzardi, Bologna, Italy
| | | | | | - Paolo Tolomeo
- Azienda Ospedaliera Universitaria di Ferrara, Ferrara, Italy
| | | | | | | | - Andrea Rognoni
- Azienda Ospedaliera Universitaria Maggiore della Carità, Novara, Italy
| | | | - Luca Franchin
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Andrea Borin
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Francesco Bruno
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | | | | | | | | | | | | | | | - Antonio Montefusco
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Pierluigi Omedè
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Mauro Pennone
- Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | | | | | | |
Collapse
|
12
|
Rondanelli M, Cereda E, Klersy C, Faliva M, Peroni G, Nichetti M, Gasparri C, Iannello G, Spadaccini D, Infantino V, Perna S. IMPROVING REHABILITATION IN SARCOPENIA (IRIS) BY MUSCLE-TARGETED NUTRITIONAL SUPPORT: A DOUBLE-BLIND RCT. Nutrition 2020. [DOI: 10.1016/j.nut.2020.110923] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
13
|
Lupi A, Ugo F, De Martino L, Infantino V, Iannaccone M, Iorio S, Di Leo A, Colangelo S, Zanera M, Schaffer A, Persampieri S, Garbo R, Senatore G. Real-World Experience With a Tapered Biodegradable Polymer-Coated Sirolimus-Eluting Stent in Patients With Long Coronary Artery Stenoses. Cardiol Res 2020; 11:219-225. [PMID: 32595806 PMCID: PMC7295557 DOI: 10.14740/cr1055] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2020] [Accepted: 04/20/2020] [Indexed: 12/14/2022] Open
Abstract
Background Treatment of long coronary stenoses (LCS) with long tapered drug-eluting stents (LT-DES) would offer clinical and economic benefits. However, the feasibility of an interventional strategy based upon the systematic LCS treatment with an LT-DES has not been evaluated so far. Methods We performed a multicenter prospective study including consecutive patients with: 1) An LCS > 25 mm at coronary angiography; 2) An attempt to fix the LCS with a single BioMime Morph™ stent, a novel LT-DES available from 30 to 60 mm long. The primary efficacy endpoint was procedural success. The secondary safety endpoints were post-procedural TIMI3 flow, stent detachment during delivery, acute stent thrombosis and in-hospital mortality. Results From February 2017 to March 2018, we recorded 272 patients with an LCS and an attempt to deploy an LT-DES during percutaneous coronary intervention (PCI) (69.3 ± 11.4 years, 75.7% males, 25.7% diabetic and 43.8% with acute coronary syndromes, mean LCS length 48.8 ± 9.5 mm). LT-DES deployment was successful in 262 patients (96.3%), and failure occurred without stent detachment or other complications. Final TIMI3 flow was present in 270 (99.3%) patients. In-hospital death occurred in five patients (1.8%), with no case of acute stent thrombosis, recurrent myocardial infarction or repeated revascularization. Conclusion In this real-world study, a strategy of fixing LCS with a single LT-DES was feasible and safe, with a high rate of procedural success and a low rate of in-hospital complications. More extensive randomized studies are warranted to assess the potential clinical and economic benefits of LT-DES.
Collapse
Affiliation(s)
- Alessandro Lupi
- SOC Cardiologia, Ospedali Riuniti di Domodossola e Verbania, Italy
| | - Fabrizio Ugo
- Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy
| | | | | | - Mario Iannaccone
- Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy
| | - Sergio Iorio
- SOC Cardiologia, Ospedali Riuniti di Domodossola e Verbania, Italy
| | - Angelo Di Leo
- Department of Cardiology, Ospedale Civile, Cirie, Italy
| | - Salvatore Colangelo
- Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy
| | - Marco Zanera
- Department of Cardiology, Ospedale Civile, Cirie, Italy
| | - Alon Schaffer
- SOC Cardiologia, Ospedali Riuniti di Domodossola e Verbania, Italy
| | | | - Roberto Garbo
- Department of Invasive Cardiology, Ospedale San Giovanni Bosco, Turin, Italy
| | | |
Collapse
|
14
|
D'Ascenzo F, Gallone G, Boccuzzi G, Cortese B, Di Biasi M, Capodanno D, Vicinelli P, Infantino V, Poli A, Grigis G, Varbella F, De Ferrari GM, Ielasi A. Dual antiplatelet therapy strategies and clinical outcomes in patients treated with polymer-free biolimus A9-coated stents. EUROINTERVENTION 2020; 15:e1358-e1365. [DOI: 10.4244/eij-d-19-00450] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
15
|
Quadri G, Cerrato E, Porto I, Cavallino C, Bettari L, Tomassini F, Franzè A, Ferrari F, Iannaccone M, Pavani M, Rametta F, Giachet AT, Lo Savio L, Campo G, Demarchi A, Rolfo C, Bordoni E, Infantino V, Bernelli C, Gambino A, Cassano F, Varbella F. TCT-470 Acute Management of Patients With Spontaneous Coronary Artery Dissection: The DISCO (DIssezioni Spontanee COronariche) Italian Registry. J Am Coll Cardiol 2019. [DOI: 10.1016/j.jacc.2019.08.562] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
16
|
Gasparri C, Perna S, Spadaccini D, Alalwan T, Girometta C, Infantino V, Rondanelli M. Is vitamin D-fortified yogurt a value-added strategy for improving human health? A systematic review and meta-analysis of randomized trials. J Dairy Sci 2019; 102:8587-8603. [PMID: 31400903 DOI: 10.3168/jds.2018-16046] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2018] [Accepted: 06/06/2019] [Indexed: 12/31/2022]
Abstract
Yogurt is a good source of probiotics, calcium, and proteins, but its content of vitamin D is low. Therefore, yogurt could be a good choice for vitamin D fortification to improve the positive health outcomes associated with its consumption. The primary aim of this systematic review and meta-analysis was to investigate the effect of vitamin D-fortified yogurt compared with plain yogurt on levels of serum 25-hydroxy vitamin D (25OHD). The secondary aim was to evaluate the effect of fortified yogurt on parathyroid hormone, anthropometric parameters, blood pressure, glucose metabolism, and lipid profile. We searched PubMed, Scopus, and Google Scholar for eligible studies; that is, randomized controlled trials (RCT) that compared vitamin D-fortified yogurt with control treatment without any additional supplement. Random-effects models were used to estimate pooled effect sizes and 95% confidence intervals. Findings from 9 RCT (n = 665 participants) that lasted from 8 to 16 wk are summarized in this review. The meta-analyzed mean differences for random effects showed that vitamin D-fortified yogurt (from 400 to 2,000 IU) increased serum 25OHD by 31.00 nmol/L. In addition, vitamin D-fortified yogurt decreased parathyroid hormone by 15.47 ng/L, body weight by 0.92 kg, waist circumference by 2.01 cm, HOMA-IR by 2.18 mass units, fasting serum glucose by 22.54 mg/dL, total cholesterol by 13.38 mg/dL, and triglycerides by 30.12 mg/dL compared with the controlled treatments. No publication bias was identified. Considerable between-study heterogeneity was observed for most outcomes. Vitamin D-fortified yogurt may be beneficial in improving serum 25OHD, lipid profile, glucose metabolism, and anthropometric parameters and decreasing parathyroid hormone level in pregnant women and adult and elderly subjects with or without diabetes, prediabetes, or metabolic syndrome.
Collapse
Affiliation(s)
- C Gasparri
- Department of Public Health, Experimental and Forensic Medicine, Section of Human Nutrition, Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona, University of Pavia, 27100 Pavia, Italy.
| | - S Perna
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, PO Box 32038, Kingdom of Bahrain
| | - D Spadaccini
- Department of Public Health, Experimental and Forensic Medicine, Section of Human Nutrition, Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona, University of Pavia, 27100 Pavia, Italy
| | - T Alalwan
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, PO Box 32038, Kingdom of Bahrain
| | - C Girometta
- Department of Earth and Environmental Sciences, Mycology and Plant Pathology Laboratory, University of Pavia, 27100 Pavia, Italy
| | - V Infantino
- Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, 70121 Bari, Italy
| | - M Rondanelli
- IRCCS Mondino Foundation, 27100 Pavia, Italy; Department of Public Health, Experimental and Forensic Medicine, Unit of Human and Clinical Nutrition, University of Pavia, 27100 Pavia, Italy
| |
Collapse
|
17
|
D'Ascenzo F, Gaido L, Bernardi A, Saglietto A, Franzé A, Ielasi A, Trabattoni D, Di Biasi M, Infantino V, Rognoni A, Helft G, Gangor A, Latini RA, De Luca L, Mitomo S, Ugo F, Smolka G, Huczek Z, Cortese B, Capodanno D, Chieffo A, Piazza F, di Mario C, Poli A, D'Urbano M, Romeo F, Giammaria M, Varbella F, Sheiban I, Escaned J, De Ferrari GM. Safety and efficacy of polymer-free biolimus-eluting stents versus ultrathin stents in unprotected left main or coronary bifurcation: A propensity score analysis from the RAIN and CHANCE registries. Catheter Cardiovasc Interv 2019; 95:522-529. [PMID: 31385427 DOI: 10.1002/ccd.28413] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2019] [Revised: 06/05/2019] [Accepted: 07/10/2019] [Indexed: 11/08/2022]
Abstract
OBJECTIVES Evaluate safety and efficacy of polymer-free biolimus-eluting stents (PF-BESs) versus ultrathin stents in unprotected left main (ULM) or bifurcation. BACKGROUND PF-BESs due to reduced length of dual antiplatelet therapy (DAPT) are increasingly used. However, there are limited data about safety and efficacy for ULM or bifurcation. METHODS We selected all-patients treated for ULM or bifurcation from two multicenter real life registries (RAIN [NCT03544294] evaluating ultrathin stents, CHANCE [NCT03622203] appraising PF-BES). After propensity score with matching, the primary endpoint was major adverse cardiac events (MACE; a composite of all-cause death, myocardial infarction, target lesion revascularization [TLR], and stent thrombosis [ST]), while its components along with target vessel revascularization (TVR) secondary endpoints. RESULTS Three thousand and three patients treated with ultrathin stents and 446 with PF-BESs, resulting respectively in 562 and 281 after propensity score with matching (33 and 22%, respectively, with ULM disease). After 12 (8-20) months, rates of MACE were similar (9 vs. 8%, p = 0.56) without difference in TLR and ST (3.0 vs. 1.7%, p = .19 and 1.8 vs. 1.1%, p = .42). These results were consistent for ULM group (3 vs. 1.7% and 1.8 vs. 1.1%, p = .49 and .76), for non-ULM group (2.1 vs. 3.4%, p = .56 and 1.2 vs. 1.7%, p = .78) and for two-stent strategy (8.7 vs. 4.5% and 4.3 vs. 3.2%, p = .75 and .91). Among patients treated with 1 month of DAPT in both groups, those with ultrathin stents experienced higher rates of MACE related to all-cause death (22 vs. 12%, p = .04) with higher although not significant rates of ST (3 vs. 0%, p = .45). CONCLUSIONS PF-BES implanted on ULM or BiF offered freedom from TLR and ST comparable to ultrathin stents. PF-BESs patients assuming DAPT for 1 month experienced a lower despite not significant incidence of ST.
Collapse
Affiliation(s)
- Fabrizio D'Ascenzo
- Division of Cardiology, A.O.U. Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - Luca Gaido
- Division of Cardiology, Ospedale Maria Vittoria, Turin, Italy
| | - Alessandro Bernardi
- Division of Cardiology, A.O.U. Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - Andrea Saglietto
- Division of Cardiology, A.O.U. Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - Alfonso Franzé
- Division of Cardiology, A.O.U. Città della Salute e della Scienza, University of Turin, Turin, Italy
| | - Alfonso Ielasi
- Clinical and Interventional Cardiology Unit, Sant'Ambrogio Cardio-Thoracic Center, Milan, Italy
| | - Daniela Trabattoni
- Department of Cardiovascular Sciences, IRCCS Centro Cardiologico Monzino, Milan, Italy.,Division of Cardiology, University of Milan, Milan, Italy
| | - Maurizio Di Biasi
- Cardiology Unit, ASST Fatebenefratelli/Sacco, Sacco Hospital, Milan, Italy
| | | | - Andrea Rognoni
- Coronary Care Unit and Catheterization Laboratory, A.O.U. Maggiore della Carità, Novara, Italy
| | - Gerard Helft
- Division of Cardiology, Pierre and Marie Curie University, Paris, France
| | - Andrea Gangor
- Division of Cardiology, Ospedale Maria Vittoria, Turin, Italy
| | - Roberto A Latini
- Interventional Cardiology, ASST Fatebenefratelli-Sacco, Milan, Italy
| | - Leonardo De Luca
- Division of Cardiology, S. Giovanni Evangelista Hospital, Tivoli, Rome, Italy
| | - Satoru Mitomo
- Department of Cardiovascular Medicine, Nippon Medical School, Bunkyo-ku, Tokyo, Japan
| | - Fabrizio Ugo
- Dipartimento di Cardiologia, Ospedale San Giovanni Bosco, Italy
| | - Grzegorz Smolka
- Department of Cardiology, Medical University of Silesia, Katowice, Poland
| | - Zenon Huczek
- Division of Cardiology, University Clinical Hospital, Warsaw, Poland
| | | | - Davide Capodanno
- Division of Cardiology, Cardio-Thoracic-Vascular Department, Azienda Ospedaliero Universitaria "Policlinico-Vittorio Emanuele", Catania, Italy
| | - Alaide Chieffo
- Division of Cardiology, San Raffaele Scientific Institute, Milan, Italy
| | - Fabio Piazza
- Cardiology Unit-Catheterization Laboratory, SS. Annunziata Hospital, University Hospital of Sassari, Sassari, Italy
| | - Carlo di Mario
- Structural Interventional Cardiology, Careggi University Hospital, Florence, Italy
| | - Arnaldo Poli
- ASST Milanese Ovest, Legnano Civil Hospital, Legnano, Milan, Italy
| | - Maurizio D'Urbano
- Cardiology Unit, ASST Milanese Ovest, Magenta Hospital, Magenta, Milan, Italy
| | - Francesco Romeo
- Department of Medicine, Università degli Studi di Roma 'Tor Vergata', Rome, Italy
| | | | - Ferdinando Varbella
- Department of Cardiology, Infermi Hospital, Rivoli, Italy.,Department of Cardiology, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy
| | - Imad Sheiban
- Division of Cardiology, Interventional Cardiology Pederzoli Hospital Peschiera del Garda, Verona, Italy
| | - Javier Escaned
- Department of Cardiology, Hospital Clinico San Carlos, Madrid, Spain
| | - Gaetano M De Ferrari
- Division of Cardiology, A.O.U. Città della Salute e della Scienza, University of Turin, Turin, Italy
| |
Collapse
|
18
|
Perna S, Alalwan TA, Spadaccini D, Al-Thawadi S, Gasparri C, Isu A, Riva A, Alaali Z, Iannello G, Allegrini P, Infantino V, Peroni G, Rondanelli M. Comparison between Bioimpedance Analysis and Dual-Energy X-ray Absorptiometry in assessment of body composition in a cohort of elderly patients aged 65-90 years. Adv Gerontol 2019; 32:1023-1033. [PMID: 32160444] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
We compare bioimpedance analysis (BIA) with dual-energy X-ray absorptiometry (DXA) in the assessment of free fat mass (FFM), fat mass (FM) and percentage of body fat under different conditions in relation to age categories, hydration parameters, body mass index (BMI) and sarcopenia. A cross-sectional analysis of body composition was estimated by BIA and DXA in 379 hospitalized elderly patients. In addition, estimates of FFM, FM and percentage of body fat were investigated across different conditions. Paired t-tests, Bland-Altman plot and intraclass correlation coefficient analysis were used to compare methods. Data showed an underestimation of means (BIA versus DXA) of FFM (women: 0,97 kg, p<0,01; men: 1,99 kg; p<0,01), and an overestimation of both the FM (women: +1,11 kg; p<0,01; men: +1,67 kg; p<0,01) and percentage of body fat (women: +2,07 %, p<0,01; men: +2,82 %, p<0,01). BIA underestimated FFM and overestimated FM and percentage of body fat in patients from the age group of 75 to 85 years, in patients with a total body water content <60%, in underweight and normal weight patients and in patients with sarcopenia (p<0,01). The intraclass coefficient results were indicative of poor reproducibility between BIA and DXA for FFM (women: +0,197; men: +0,250) and FM (women: +0,141; men +0,144). BIA is a good alternative for estimation of FFM and FM only in overweight or obese patients or in patients with good hydration status. BIA, on the other hand, is not an accurate method for assessing FFM in sarcopenic patients.
Collapse
Affiliation(s)
- S Perna
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, P.O. Box 32038 Kingdom of Bahrain
| | - T A Alalwan
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, P.O. Box 32038 Kingdom of Bahrain
| | - D Spadaccini
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia, Pavia, 27100 Italy, e-mail:
| | - S Al-Thawadi
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, P.O. Box 32038 Kingdom of Bahrain
| | - C Gasparri
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia, Pavia, 27100 Italy, e-mail:
| | - A Isu
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia, Pavia, 27100 Italy, e-mail:
| | - A Riva
- Research and Development Unit, Indena, Milan, 20139 Italy
| | - Z Alaali
- Department of Biology, College of Science, University of Bahrain, Sakhir Campus, P.O. Box 32038 Kingdom of Bahrain
| | - G Iannello
- General Management, Azienda di Servizi alla Persona di Pavia, Pavia, 27100 Italy
| | - P Allegrini
- General Management, Azienda di Servizi alla Persona di Pavia, Pavia, 27100 Italy
| | - V Infantino
- Department of Biomedical Sciences and Human Oncology, University of Bari Aldo Moro, 70121 Italy
| | - G Peroni
- Endocrinology and Nutrition Unit, Azienda di Servizi alla Persona «Istituto Santa Margherita», University of Pavia, Pavia, 27100 Italy, e-mail:
| | - M Rondanelli
- IRCCS Mondino Foundation, Pavia, 27100 Italy
- Department of Public Health, Experimental and Forensic Medicine, Unit of Human and Clinical Nutrition, University of Pavia, Pavia, 27100 Italy
| |
Collapse
|
19
|
Stefanizzi P, Bianchi FP, De Nitto S, Infantino V, Tafuri S. Adverse events following Men B vaccine and causality assessment: data from Apulia Region (Italy). Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky214.165] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Bianchi FP, Stefanizzi P, De Nitto S, Infantino V, Tafuri S. Long term immunogenicity of anti-measles vaccine: a study among students of a South Italy University. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky214.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- FP Bianchi
- Department of Biomedical Science and Oncology, University of Study of Bari, Bari, Italy
| | - P Stefanizzi
- Department of Biomedical Science and Oncology, University of Study of Bari, Bari, Italy
| | - S De Nitto
- Department of Biomedical Science and Oncology, University of Study of Bari, Bari, Italy
| | - V Infantino
- Department of Biomedical Science and Oncology, University of Study of Bari, Bari, Italy
| | - S Tafuri
- Department of Biomedical Science and Oncology, University of Study of Bari, Bari, Italy
| |
Collapse
|
21
|
Ielasi A, D'Ascenzo F, Di Biasi M, Latini RA, Senatore G, Grigis G, Maiorana F, Colombotto C, Infantino V, Vizzi V, Cortese B, D'Amico M, Tespili M. P6378A polymer-free biolimus-coated stent for the management of real-world high bleeding risk patients with coronary artery disease. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p6378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- A Ielasi
- Bolognini Hospital, Cardiology Division, Seriate (BG), Italy
| | - F D'Ascenzo
- Hospital 'Città della Salute e della Scienza di Torino', Cardiology, Turin, Italy
| | - M Di Biasi
- Luigi Sacco Hospital, Cardiology, Milan, Italy
| | - R A Latini
- Fatebenefratelli Hospital, Cardiology, Milan, Italy
| | - G Senatore
- Civic Hospital of Cirie, Cardiology, Ciriè (Turin), Italy
| | - G Grigis
- Bolognini Hospital, Cardiology Division, Seriate (BG), Italy
| | - F Maiorana
- Bolognini Hospital, Cardiology Division, Seriate (BG), Italy
| | - C Colombotto
- Hospital 'Città della Salute e della Scienza di Torino', Cardiology, Turin, Italy
| | - V Infantino
- Civic Hospital of Cirie, Cardiology, Ciriè (Turin), Italy
| | - V Vizzi
- Luigi Sacco Hospital, Cardiology, Milan, Italy
| | - B Cortese
- Fatebenefratelli Hospital, Cardiology, Milan, Italy
| | - M D'Amico
- Hospital 'Città della Salute e della Scienza di Torino', Cardiology, Turin, Italy
| | - M Tespili
- Bolognini Hospital, Cardiology Division, Seriate (BG), Italy
| |
Collapse
|
22
|
Perna S, Guido D, Faliva M, Infantino V, Peroni G, Naso M, Rondanelli M. Association among insulin-resistance indexes and C-reactive protein in overweight and obese men. Nutrition 2016. [DOI: 10.1016/j.nut.2015.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
23
|
Perna S, Bologna C, Isu A, Miccono A, Infantino V, Faliva M, Guerriero F, Sgarlata C, Degli Agosti I, Rondanelli M. P-357: Osteoporosis in elderly women during hospitalization. Intention to treat following FRAX index cutoff. Eur Geriatr Med 2015. [DOI: 10.1016/s1878-7649(15)30454-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
24
|
Cerrato E, Rolfo C, Tomassini F, Montali N, Gambino A, Infantino V, Palacio Restrepo S, Baricocchi D, Nevola R, Gagnor A, Varbella F. [MGuard Dacron mesh-covered stent implantation in patients with ST-elevation myocardial infarction and high thrombotic burden: in-hospital and long-term outcome in a single high-volume center]. G Ital Cardiol (Rome) 2015; 16:373-379. [PMID: 26156698 DOI: 10.1714/1934.21034] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
BACKGROUND The MGuard (MG) is a stainless-steel closed cell stent covered with an ultra-thin polymer mesh sleeve, which has the purpose of ensuring reduced distal embolization of thrombotic material, thus lowering the risk of no-reflow/slow-flow phenomena. Only few data are available that evaluated the usefulness of the MG stent in patients with ST-elevation myocardial infarction (STEMI) with a high thrombotic burden. METHODS We prospectively collected data of patients presenting with STEMI and high thrombotic burden (thrombus burden grade 4 or 5 according to the TIMI score) who underwent primary percutaneous coronary intervention (PCI) with MG stent implantation in our center. Lesions involving a bifurcation or very calcified and tortuous vessels were not included. Final TIMI 3 flow, normal myocardial blush grade (MBG), and complete ST-segment resolution were defined as short-term endpoints, whereas major adverse cardiovascular events were evaluated during follow-up. RESULTS From August 2008 to June 2013, the MG stent was implanted in 104 (9.3%) of 1108 patients who underwent primary PCI. Cardiogenic shock on admission was present in 4 patients (3.8%). Final TIMI 3 flow was achieved in 97.1% of patients, MBG 3 in 56.7%, and regression of ST-segment elevation ≥70% within 90 min was recorded in 64.4% of patients. In-hospital mortality was 2.9% (n=3), and at a mean follow-up of 455±430 days overall major adverse cardiovascular events were 11 (10.6%). Cardiac death occurred in 5 patients (4.9%) and stent thrombosis in 2 (1.9%). CONCLUSIONS In selected patients with STEMI undergoing primary PCI, the use of the mesh-covered MG stent in vessels with high thrombotic burden despite thrombus aspiration was effective and safe both immediately and at mid-term follow-up.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | - Rosa Nevola
- Cardiologia, Ospedali degli Infermi, Rivoli (TO)
| | | | | |
Collapse
|
25
|
Biasco L, Infantino V, Orzan F, Vicentini S, Rovera C, Longo G, Chinaglia A, Belli R, Allais G, Gaita F. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt. J Cardiol 2014; 64:390-4. [PMID: 24713153 DOI: 10.1016/j.jjcc.2014.02.023] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/04/2013] [Revised: 01/25/2014] [Accepted: 02/13/2014] [Indexed: 11/25/2022]
Abstract
OBJECTIVES To retrospectively evaluate the impact on daily activities of transcatheter closure of patent foramen ovale (PFO) versus medical therapy in patients with migraine and to analyze the role of the residual shunt after PFO closure. BACKGROUND While non-controlled observational studies reported an improvement of migraine after PFO closure, a randomized trial has shown no benefit of such an intervention. The role of residual shunt after PFO closure is also poorly known. METHODS Out of 217 patients with migraine and echocardiographic evidence of PFO, 89 were managed with percutaneous PFO closure (Group A) while 128 were medically treated (Group B). All MIDAS questionnaires were obtained at the first evaluation and repeated at least 6 months after the index evaluation or after the PFO closure. All the patients were also asked to give a subjective estimate of their migraine status. A postprocedural transcranial Doppler study was available in 70 patients in Group A. RESULTS The mean basal MIDAS score did not differ between the two groups (p = 0.859). After a mean follow-up (FU) of 1399 ± 982 days the MIDAS score decreased significantly in both groups (Group A baseline vs FU, p < 0.001; Group B baseline vs FU, p < 0.001), but no differences were observed between groups (p = 0.204). However a significantly higher number of Group A patients reported a perceived clinical benefit or the disappearance of migraine compared to Group B (p < 0.001). Patients with moderate or severe residual right to left shunt were no more likely to have an higher MIDAS score or to complain of migraine than those with mild or no shunt. CONCLUSIONS Although the overall evolution of migraine is not significantly different, the abolition of migraine occurs in a larger proportion after PFO closure.
Collapse
Affiliation(s)
- Luigi Biasco
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
| | - Vincenzo Infantino
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Fulvio Orzan
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Silvia Vicentini
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Chiara Rovera
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Giada Longo
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | | | - Riccardo Belli
- Division of Cardiology, Ospedale Maria Vittoria, Turin, Italy
| | - Gianni Allais
- Women's Headache Center, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| | - Fiorenzo Gaita
- Division of Cardiology, Department of Medical Sciences, Azienda Ospedaliera Universitaria Città della Salute e della Scienza di Torino, Turin, Italy
| |
Collapse
|
26
|
Tomassini F, Gagnor A, Montali N, Gambino A, Bollati M, Infantino V, Rigattieri S, Varbella F. Impact of thrombus aspiration during primary percutaneous coronary intervention in cardiogenic shock complicating ST-segment elevation myocardial infarction. Cardiovascular Revascularization Medicine 2013; 14:307-10. [DOI: 10.1016/j.carrev.2013.08.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2013] [Revised: 08/14/2013] [Accepted: 08/19/2013] [Indexed: 11/29/2022]
|
27
|
Biasco L, Vicentini S, Infantino V, Longo G, Rovera C, Chinaglia A, Orzan F, Gaita F. Evolution of migraine after trans-catheter closure of patent forame ovale. Eur Heart J 2013. [DOI: 10.1093/eurheartj/eht308.p2194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
28
|
Menga A, Infantino V, Iacobazzi F, Convertini P, Palmieri F, Iacobazzi V. Insight into mechanism of in vitro insulin secretion increase induced by antipsychotic clozapine: role of FOXA1 and mitochondrial citrate carrier. Eur Neuropsychopharmacol 2013; 23:978-87. [PMID: 22959654 DOI: 10.1016/j.euroneuro.2012.08.015] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/03/2012] [Revised: 08/03/2012] [Accepted: 08/20/2012] [Indexed: 12/13/2022]
Abstract
The use of clozapine and other antipsychotic drugs is known to be associated with a number of adverse metabolic side effects, including diabetes mellitus. These side effects could be, at least in part, the result of impaired islet cell function and abnormal insulin secretion, although the underlying mechanisms are unknown. The aim of this study is the identification of targets for clozapine related to the abnormal insulin secretion. We identify a specific activation of the transcriptional factor FOXA1, but not FOXA2 and FOXA3, by clozapine in HepG2 cells. Clozapine enhances FOXA1 DNA-binding and its transcriptional activity, increasing mitochondrial citrate carrier gene expression, which contains a FOXA1 site in its promoter. Haloperidol, a conventional antipsychotic drug, does not determine any increase of FOXA1 gene expression. We also demonstrate that clozapine upregulates FOXA1 and CIC gene expression in INS-1 cells only at basal glucose concentration. In addition, we find that abnormal insulin secretion in basal glucose conditions could be completely abolished by FOXA1 silencing in INS-1 cells treated with clozapine. The identification of FOXA1 as a novel target for clozapine may shed more light to understand molecular mechanism of abnormal insulin secretion during clozapine treatment.
Collapse
Affiliation(s)
- A Menga
- Department of Biosciences, Biotechnology and Pharmacological Sciences, University of Bari, Via Orabona 4, 70125 Bari, Italy
| | | | | | | | | | | |
Collapse
|
29
|
Tomassini F, Gagnor A, Montali N, Gambino A, Bollati M, Infantino V, Tizzani E, Varbella F. Is percutaneous coronary intervention of unprotected left main coronary artery via transradial approach feasible for skilled transfemoral operators? Initial experience in an unselected population. Cardiovascular Revascularization Medicine 2013; 14:193-6. [DOI: 10.1016/j.carrev.2013.04.007] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/08/2013] [Revised: 04/18/2013] [Accepted: 04/19/2013] [Indexed: 11/26/2022]
|
30
|
Laghezza A, Pochetti G, Lavecchia A, Fracchiolla G, Faliti S, Piemontese L, Di Giovanni C, Iacobazzi V, Infantino V, Montanari R, Capelli D, Tortorella P, Loiodice F. New 2-(aryloxy)-3-phenylpropanoic acids as peroxisome proliferator-activated receptor α/γ dual agonists able to upregulate mitochondrial carnitine shuttle system gene expression. J Med Chem 2012; 56:60-72. [PMID: 23171045 DOI: 10.1021/jm301018z] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The preparation of a series of 2-(aryloxy)-3-phenylpropanoic acids, resulting from the introduction of different substituents into the biphenyl system of the previously reported peroxisome proliferator-activated receptor α/γ (PPARα/γ) dual agonist 1, allowed the identification of new ligands with higher potency on PPARα and fine-tuned moderate PPARγ activity. For the most promising stereoisomer (S)-16, X-ray and calorimetric studies in PPARγ revealed, at high ligand concentration, the presence of two molecules simultaneously bound to the receptor. On the basis of these results and docking experiments in both receptor subtypes, a molecular explanation was provided for its different behavior as a full and partial agonist of PPARα and PPARγ, respectively. The effects of (S)-16 on mitochondrial acylcarnitine carrier and carnitine-palmitoyl-transferase 1 gene expression, two key components of the carnitine shuttle system, were also investigated, allowing the hypothesis of a more beneficial pharmacological profile of this compound compared to the less potent PPARα agonist fibrates currently used in therapy.
Collapse
Affiliation(s)
- A Laghezza
- Dipartimento di Farmacia-Scienze del Farmaco and ‡Laboratorio di Biochimica e Biologia Molecolare, Dipartimento di Bioscienze, Biotecnologie e Biofarmaceutica, Università degli Studi di Bari "Aldo Moro", 70126 Bari, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Gagnor A, Tomassini F, Romagnoli E, Montali N, Giolitto S, Tizzani E, Infantino V, Varbella F. Primary angioplasty in ST-elevation myocardial infarction due to unprotected left-main coronary disease in a high-volume catheterization center without on-site surgery facilities: immediate and medium-term outcome: the STEMI-Placet Registry. J Invasive Cardiol 2012; 24:645-649. [PMID: 23220979] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
BACKGROUND Very few data have been published for ST-elevation myocardial infarction (STEMI) caused by unprotected left main coronary artery (ULMCA) and very little is known about the results in this subgroup of patients in a hospital with high-volume catheterization laboratories (cath labs) without on-site cardiosurgery. METHODS AND RESULTS From January 2004 to December 2009, a total of 38 patients with evolving STEMI and ULMCA as the culprit lesion treated with primary angioplasty were enrolled in our registry. Despite dramatic clinical presentation (73.7% cardiogenic shock, 15.8% cardiac arrest and resuscitation maneuvers, 81.6% additive EuroSCORE >13, and 89.5% distal bifurcation involvement), angiographic success was obtained in 84.2% and final TIMI 3 flow was achieved in 34 (89.5%), while target lesion failure occurred in 47.4% (mostly [42.1%] during the in-hospital phase). Most of the patients discharged from hospital had no events at follow-up (47.4%), and notably no target lesion revascularization was required during the follow-up phase. CONCLUSIONS Primary angioplasty in patients presenting with ULMCA as the culprit lesion in a STEMI setting appears to be technically feasible and a good alternative to surgical revascularization. Mortality in this group of patients tends to be high, but lower than mortality of untreated patients; the majority of events are concentrated during the in-hospital phase. Procedural delay related to activation of operator's staff in off-duty hours doesn't correlate with a worse prognosis.
Collapse
Affiliation(s)
- Andrea Gagnor
- Ospedale degli Infermi, ASL TO 3, Cardiology Department, Rivoli (Turin), Italy.
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Gagnor A, Tomassini F, Montali N, Tizzani E, Giolitto S, Infantino V, Favro E, Varbella F. Chronic total occlusion treatment as a health insurance: collateral recruitability and bidirectionality. J Cardiovasc Med (Hagerstown) 2012; 14:899-901. [PMID: 22472848 DOI: 10.2459/jcm.0b013e3283528fcb] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- Andrea Gagnor
- Divisione di Cardiologia, Ospedale degli Infermi, Rivoli (TO), Italy
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Gagnor A, Tomassini F, Romagnoli E, Infantino V, Rosa Brusin MC, Maria C, Tripodi R, Sangiorgi G, Varbella F. Percutaneous left main coronary disease treatment without on-site surgery back-up in patients with acute coronary syndromes. Catheter Cardiovasc Interv 2011; 79:979-87. [DOI: 10.1002/ccd.23225] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2011] [Accepted: 05/01/2011] [Indexed: 02/04/2023]
|
34
|
Scacciatella P, Ebrille E, Infantino V, Amato G, Levis M, Marra S. Left main minimal plaque burden complicated by an acute massive thrombosis: diagnostic and therapeutic strategies. J Cardiovasc Med (Hagerstown) 2011; 12:692-4. [PMID: 21224779 DOI: 10.2459/jcm.0b013e328338936d] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
35
|
Tomassini F, Gagnor A, Migliardi A, Tizzani E, Infantino V, Giolitto S, Conte MR, Lanza GA, Gnavi R, Varbella F. Cardiogenic shock complicating acute myocardial infarction in the elderly: predictors of long-term survival. Catheter Cardiovasc Interv 2011; 78:505-11. [PMID: 21953748 DOI: 10.1002/ccd.22911] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/01/2010] [Accepted: 11/22/2010] [Indexed: 11/06/2022]
Abstract
BACKGROUND Cardiogenic shock (CS) is a severe complication of acute myocardial infarction (AMI), associated with a high mortality. A significant improvement in survival has been reported with immediate coronary revascularization. However, there is no clear evidence of such an improvement amongst older patients. The aim of our work was to evaluate in-hospital and long-term outcomes in the group of elderly AMI patients with CS (≥75 years old). METHODS We collected data of 157 consecutive AMI patients with CS who underwent percutaneous coronary intervention (PCI) and compared clinical and procedural characteristics and in-hospital and long-term outcomes between patients <75 years and patients ≥75 years old. RESULTS There were 58 patients (36.9%) with age ≥75 years and 99 patients (63.1%) with age <75 years. Patients were followed up for an average period of 34 months (range 5-69). In-hospital and long-term mortality was significantly higher in the older group (55 vs. 25%, P < 0.0001; and 62.1 vs. 37.3%, P = 0.005, respectively). Multivariate predictors of in-hospital mortality were age ≥75 years (hazard ratio 1.81, 95% CI 1.006-3.27, P = 0.04) and PCI failure (hazard ratio 2.67, 95% CI 1.34-5.307, P = 0.005), whereas, the only multivariate predictor of long-term mortality was PCI failure (hazard ratio 2.88, 95% CI 1.52-5.46, P = 0.001). Age ≥75 years showed only a trend toward statistical significance (hazard ratio 1.62, 95% CI 0.96-2.76, P = 0.07). CONCLUSIONS In elderly AMI patients with CS, PCI can be performed with an acceptable risk that seems lower than that reported in most previous studies.
Collapse
|
36
|
Gagnor A, Tomassini F, Infantino V, Varbella F. Unintended stent removal during fractured-guidewire removal in emergency angioplasty. J Cardiovasc Med (Hagerstown) 2010; 10:885-6. [PMID: 19644386 DOI: 10.2459/jcm.0b013e32832d8833] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
We report a case of removal of fractured guidewire and stent during an emergency angioplasty for an acute coronary syndrome.
Collapse
Affiliation(s)
- Andrea Gagnor
- Divisione di cardiologia, Ospedale degli Infermi, Rivoli, Italy.
| | | | | | | |
Collapse
|
37
|
Sillano D, Infantino V, Biondi-Zoccai G, Sheiban I. Management of restenosis after drug-eluting stent placement for unprotected left main disease. Interv Cardiol 2010. [DOI: 10.2217/ica.09.144] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
|
38
|
Sheiban I, Infantino V, Bollati M. Buddy balloon to deliver a percutaneous aortic valve device: A percutaneous shoehorn? Catheter Cardiovasc Interv 2009; 74:805-7. [DOI: 10.1002/ccd.22118] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
39
|
Colombo F, Biondi-Zoccai G, Infantino V, Omedé P, Moretti C, Sciuto F, Siliquini R, Chiadò S, Trevi GP, Sheiban I. A long-term comparison of drug-eluting versus bare metal stents for the percutaneous treatment of coronary bifurcation lesions. Acta Cardiol 2009; 64:583-8. [PMID: 20058502 DOI: 10.2143/ac.64.5.2042686] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
BACKGROUND After the first exciting results on drug-eluting stents (DES), many concerns have been raised on their potential risk for late stent thrombosis. Whereas DES appear beneficial at early and mid-term for coronary bifurcation lesions, no data are available on their long-term safety in this setting in comparison to bare metal stents (BMS). We thus aimed to appraise the long-term (> 2 years) outcomes of patients with bifurcation lesions treated with DES vs. BMS. METHODS We abstracted baseline, procedural and follow-up data on all patients with bifurcation coronary lesions (both branches with reference vessel diameter > 2.0 mm) treated with stent implantation at our centre. The primary end-point was the long-term (> 2 years) rate of major adverse cardiac events (MACE, i.e. cardiac death, myocardial infarction, coronary artery bypass grafting and target vessel revascularization). RESULTS A total of 315 patients and 334 lesions were included, 84.4% treated with DES, and 15.6% treated with BMS. The side branch was stented in 108 cases, according to a provisional T in 76 (22.7%), crushing in 15 (4.5%),V in 14 (4.2%), and culottes in 1 (0.3%). In-hospital MACE occurred in 4 (1.5%) patients of the DES group and 2 (4.1%) of the BMS group (P = 0.22). After 35.8 +/- 12.9 months, MACE were 72 (27.1%) vs. 24 (49%), respectively (P = 0.002), with cardiac death in 7 (2.6%) patients vs. 3 (6.1%, P = 0.20), myocardial infarction in 12 (4.5%) vs. 6 (12.2%, P = 0.42), coronary artery bypass grafting in 5 (1.9%) vs. 1 (2%, P = 0.93), target lesion revascularization in 30 (11.3%) vs. 13 (26.5%, P = 0.0042), and target vessel revascularization in 48 (18%) vs. 13 (26.5%, P = 0.16). Definite stent thrombosis occurred in 2 (0.75%) patients in the DES group vs. 1 (2%, P = 0.93) in the BMS group, whereas probable stent thrombosis was adjudicated in 5 (1.9%) vs. 2 (4%, P = 0.93). CONCLUSION This cohort study, reporting for the first time on the long-term outlook of patients treated with DES vs. BMS for coronary bifurcation lesions, supports the overall safety and efficacy of DES in comparison to BMS. Specifically, even after several years of follow-up, repeat revascularizations appeared significantly lower with DES, and stent thromboses occurred with equivalent frequency in both DES and BMS groups.
Collapse
Affiliation(s)
- Francesco Colombo
- Division of Cardiology, University of Turin, S. Giovanni Battista Molinette Hospital, Turin, Italy
| | | | | | | | | | | | | | | | | | | |
Collapse
|
40
|
Tomassini F, Varbella F, Gagnor A, Infantino V, Luceri S, Conte MR. Severe multivessel coronary spasm after sirolimus-eluting stent implantation. J Cardiovasc Med (Hagerstown) 2009; 10:485-8. [DOI: 10.2459/jcm.0b013e32831daf84] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
41
|
Varbella F, Gagnor A, Tomassini F, Infantino V, Conte MR. Immediate and long-term results of treatment of complex lesions of the left anterior descending coronary artery involving a large diagonal branch with drug-eluting stents. J Cardiovasc Med (Hagerstown) 2008; 9:1088-94. [DOI: 10.2459/jcm.0b013e328304ab09] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
42
|
Piccirillo G, Fimognari FL, Infantino V, Monteleone G, Fimognari GB, Falletti D, Marigliano V. High plasma concentrations of cortisol and thromboxane B2 in patients with depression. Am J Med Sci 1994; 307:228-32. [PMID: 8160715 DOI: 10.1097/00000441-199403000-00011] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
Modulation of the hypothalamic-pituitary-adrenal axis in major depression is thought to depend on the hypothalamus and other areas of the central nervous system, or both. Hypothalamic over-activity may be responsible for the hypercortisolism observed in 50% of depressed subjects. To investigate the relation between psychosocial factors and cardiovascular disease, morning (8 AM) plasma concentrations of cortisol and thromboxane B2 (the stable metabolite of thromboxane A2, an eicosanoid closely linked to thrombotic disorders) were measured by radioimmunoassay in 32 patients with major depression (DSM III) triggered by psychosocial events and in 9 nondepressed volunteers. The depressed patients were studied in two groups, 16 with cortisol levels under 90 ng/mL and 16 with levels over 90 ng/mL. All the healthy non-depressed subjects had cortisol values over 100 ng/mL. The depressed patients with high cortisol had significantly higher plasma TxB2 concentrations than the other two groups. In addition, plasma cortisol and TxB2 concentrations correlated significantly over the whole group of depressed patients and in the high cortisol sub-group but not in the low-cortisol sub-group or in the nondepressed subjects. These findings appear to support the recently proposed role of the hypothalamic dysfunction associated with affective disorders in the pathogenesis of cardiovascular disease.
Collapse
Affiliation(s)
- G Piccirillo
- Chair of Geriatrics, University La Sapienza, Rome, Italy
| | | | | | | | | | | | | |
Collapse
|
43
|
Poerio N, Infantino V, Demartino GR, Costa B, Condemi P, Ferro' D. [Umbilical and ocular infections due to environmental contamination by Pseudomonas aeruginosa and Staphylococcus aureus. An outbreak at the neonatal and obstetric sections of the Locri Community Hospital. Environmental microbiological research and relative results]. G Batteriol Virol Immunol 1984; 77:208-14. [PMID: 6545800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/05/2023]
Abstract
By the end of the year 1979 and the beginning of 1980 in the departments of babies and obstetrics of our hospital, we registered an epidemic episode of umbilical and ocular infection for hospitality by Pseudomonas aeruginosa and Staphylococcus aureus (about the 85% of the umbilical and conjunctival tampons sent to laboratory turned out be positive of these germs). At once we disposed a series of environmental checks; the result was that the cause of infection was originated in the wash bowl of these departments and, above all the ones fit to bath babies in the department of obstetrics. After timely measures of disinfection, further environmental checks proved the disappearing of these germs, only keeping a light positivity for the Pseudomonas in a wash bowl of the department of babies. We didn't have serious or mortal cases and all the strains by us isolated proved a good sensibility towards the antibiotics.
Collapse
|